Rchr
J-GLOBAL ID：200901075546257159   Update date: Sep. 15, 2022

Tamada Satoshi

タマダ サトシ | Tamada Satoshi
Affiliation and department：
Osaka City University Graduate School of Medicine Clinical Medicine Course

About Osaka City University Graduate School of Medicine Clinical Medicine Course


Job title： Lecturer
Research field  (1)： Urology
Research theme for competitive and other funds  (1)：
  • 泌尿器科癌の治療
Papers (120)：
  • Iguchi T, Tamada S, Kato M, Yasuda S, Machida Y, Ohmachi T, Ishii K, Iwata H, Yamamoto S, Kanamaru T, et al. Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study. International journal of clinical oncology. 2019
  • Iguchi Taro, Tamada Satoshi, Kato Minoru, Yasuda Sayaka, Otoshi Taiyo, Hamada Kosuke, Yamasaki Takeshi, Nakatani Tatsuya. Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study(和訳中). シュプリンガー・ジャパン(株) International Journal of Clinical Oncology. 2019. 24. 7. 848-856
  • Plimack Elizabeth R, Rini Brian I, Stus Viktor, Gafanov Rustem, Hawkins Robert, Nosov Dmitry, Pouliot Frederic, Soulieres Denis, Melichar Bohuslav, Vynnychenko Ihor, et al. AUTHOR INDEX. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2019. 15. 33-34
  • Rini Brian I, Plimack Elizabeth R, Stus Viktor, Gafanov Rustem, Hawkins Robert, Nosov Dmitry, Pouliot Frederic, Soulieres Denis, Melichar Bohuslav, Vynnychenko Ihor, et al. Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor risk and sarcomatoid subgroups of the phase 3 KEYNOTE-426 study. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 15
  • Iguchi Taro, Tamada Satoshi, Kato Minoru, Yasuda Sayaka, Otoshi Taiyo, Machida Yuichi, Ohmachi Tetsuji, Ishii Keiichi, Iwata Hiroyuki, Yamamoto Shinji, et al. Impact of enzalutamide and sequential flutamide and enzalutamide therapy for castration-resistant prostate cancer after bicalutamide-combined androgen blockade therapy onoverall survival: A follow-up study of randomized phase 2 trial (OCCU-CRPC study). JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 15
ｍore...
MISC (13)：
ｍore...
Books (3)：
  • 文化財学の新地平
    国立文化財機構奈良文化財研究所 2013 ISBN:9784642024082
  • 奈良文化財研究所創立60周年記念論文集
    国立文化財機構奈良文化財研究所 2012 ISBN:9784905338154
  • 相棒
    朝日新聞社 2008 ISBN:9784022644282
Lectures and oral presentations  (225)：
  • 一般施設における女性のクラミジア感染の実態調査
    (日本性感染症学会誌 2019)
  • Nivolumab・Ipilimumab併用療法後に急速な甲状腺腫大を認めた1例
    (日本内分泌学会雑誌 2019)
  • 慢性的な下腹部痛を訴える膀胱瘤を有する高齢女性に対しGenitourinary syndrome of menopauseの治療が著効した1例
    (日本排尿機能学会誌 2019)
  • 難治性前庭部痛による性交痛を有する若年女性に対するCO2フラクショナルレーザー治療経験の報告
    (日本性機能学会雑誌 2019)
  • ロボット腎部切における手技の工夫 腎門部腫瘍に対する腫瘍切離および切除面、実質縫合の工夫
    (腎癌研究会会報 2019)
ｍore...
Education (2)：
  • - 2003 Osaka City University Graduate School, Division of Medical Sciences
  • - 1997 Osaka City University Faculty of Medicine
Professional career (1)：
  • MD, PhD (Osaka City University)
Work history (1)：
  • 2007/04/01 - 現在 Osaka City University Graduate School of Medicine Clinical Medicine Course Lecturer
Association Membership(s) (5)：
日本移植学会 ,  日本癌治療学会 ,  日本Endurology and ESWL学会 ,  日本透析医学会 ,  日本泌尿器科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM